ETFMG Treatments, Testing and Advancements ETF (GERM) |
| 19.1577 -0.055 (-0.29%) 09-05 15:53 |
| Open: | 19.28 |
| High: | 19.28 |
| Low: | 19.1577 |
| Volume: | 4,828 |
| Market Cap: | 10(M) |
| PE Ratio: | 7.45 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 55.75 |
| Resistance 1: | 47.73 |
| Pivot price: | 44.67 |
| Support 1: | 43.84 |
| Support 2: | 41.44 |
| 52w High: | 20.1994 |
| 52w Low: | 16.32 |
The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Mon, 29 Jan 2024
Amplify ETFs Completes Acquisition to Reach $9.1 Billion AUM Across 31 ETFs - Yahoo Finance
Tue, 29 Aug 2023
Amplify's Christian Magoon on Purchase of ETFMG's ETFs - ETF Trends
Wed, 22 Mar 2023
Healthcare Stocks List 2026: Best Publicly Traded Companies - Bullish Bears
Mon, 20 Dec 2021
Biotech ETFs That Outperformed Last Week - Yahoo Finance
Wed, 29 Sep 2021
Pfizer, Moderna: How to invest in the future of vaccines - AFR
Wed, 26 Feb 2020
ETF Stocks 2026: Complete List of Exchange Traded Funds - Bullish Bears
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |